ARCHIVES

FTC Report Disagrees With Key Provision Of Biologics Bill Backed By Companies

This article is from The Cancer Letter archive.

Vol. 35 No. 23 | June 12, 2009

Download PDF Visit The Full Archive

Related Articles

Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival

April 27, 2012

Three Nurse Awards Made In Self Care

September 30, 1988

PHS Plans Revitalization of Commissioned Corps

July 11, 2003

XIIIth International Cancer Congress in Seattle Drawing Record Numbers Or Top Scientific Program

July 30, 1982

Workers Ignorant Of Benzidine Risk, Union tells Congress

April 3, 1987

NCI Director John Niederhuber Favors Hands-On Management, Revives Institute’s Former Organizational Structure, Abandons Senior Management Team to Work Closely With Deputies and Division Directors.

September 22, 2006